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THE IMPORTANCE OF
MANAGING PERIPHERAL VASCULAR DISEASE
For decades, cardiologists either have been uninterested or
have ignored their role as vascular medicine specialists as
well as experts in the diagnosis and management of heart
disease. Even though board certification from the American
Board of Internal Medicine is designated for cardiovascular
disease, many cardiologists are deficient in their training for
evaluation and management of noncoronary vascular dis-
ease, and those who received some training during their
fellowships are less proficient in this area of their specialty
than they are in treating cardiac disorders. In recent years,
there has been a reawakening to the cardiologist’s obliga-
tions to see patients with peripheral vascular disease and not
only manage their vascular disease but also reduce their risk
of future cardiac events, which is the predominant cause of
death in patients who initially present with aortic, peripheral
vascular, or carotid arterial atherosclerotic disease. Athero-
sclerosis is a generalized disease, and cardiologists must
direct their efforts in attenuating or reversing it no matter
how a patient initially presents. Dr. John W. Hirshfeld, Jr.,
Chair of the American College of Cardiology (ACC)
Cardiac Catheterization and Intervention Committee, has
stated, “Because noncardiac vascular disease is currently
underdiagnosed and undertreated, cardiologists as a profes-
sional group should hold a more comprehensive core knowl-
edge base of vascular medicine than they currently do.”
Today, cardiologists are often asked to perform a preop-
erative risk assessment of patients with peripheral vascular
disease undergoing noncardiac surgery (e.g., aortic aneu-
rysm resection). Many patients with peripheral vascular
disease, however, are not seen by cardiologists at all and
directly undergo either vascular surgery or vascular interven-
tion by vascular surgeons or interventional radiologists,
respectively. The screening and medical management of the
risk factors promoting the development of atherosclerotic
peripheral vascular disease (and obviously coronary artery
disease) are not adequately undertaken. Evaluation of pa-
tients with peripheral vascular disease should be a funda-
mental obligation of the cardiologist, and comprehensive
cardiovascular care for such patients includes the treatment
of hyperlipidemia, hypertension, and other risk factors for
atherosclerosis. These are important risk factors for both
coronary and peripheral vascular disease. For cardiologists
performing vascular intervention procedures in their pa-
tients, attention to the concomitant medical therapy for
risk-factor elimination or reduction is mandatory.
FELLOWSHIP TRAINING IN VASCULAR MEDICINE
The issue regarding the improvement in the training of
fellows in vascular medicine is being addressed by a task
force of ACC members (Dr. Mark A. Creager, Chair; and
Drs. John P. Cooke, Jeffrey W. Olin, and Christopher J.
White) that is writing the revised guidelines for training
that will be part the ACC Core Cardiology Training
Symposium-2 (COCATS-2). In the original COCATS-1
document (1), no specific sections on training in vascular
medicine and peripheral catheter-based interventions were
included. Dr. Creager and his writing group state that not
only are vascular diseases encountered frequently by cardio-
vascular physicians but also technological advances in im-
aging techniques and catheter-based interventions have
brought management of vascular diseases firmly into the
sphere of the cardiovascular specialist. This task force is
proposing three levels of training in vascular medicine,
where Level I will be basic training that all cardiology
fellows receive to acquire a sufficient knowledge base to care
for the many patients with vascular disease they will en-
counter in a general cardiology practice. Level II training
will be composed of additional training for fellows wishing
to develop special expertise in evaluating and managing
patients with peripheral vascular disease. Level III training
will be directed to cardiologists who wish to become skilled
in noncoronary, catheter-based vascular interventions. This
third level will contain training elements aimed at ensuring
that trainees develop both the cognitive and the technical
skills required for making the appropriate decisions regard-
ing invasive and interventional treatment of patients with
noncoronary vascular disease.
In the COCATS document, the task force writing group
will emphasize that trainees who plan a vascular medicine
track as part of their cardiovascular specialty should have
sufficient exposure to the diagnosis and treatment of periph-
eral vascular disease, aortic diseases, cerebral vascular dis-
ease, renal artery stenosis, venous thromboembolic diseases,
chronic venous disorders, lymphatic diseases, vasculitides,
atheromatous embolization, vasospastic disease, chronic ve-
nous insufficiency, and other uncommon vascular diseases.
They will need to spend time on an inpatient vascular
medicine consultation service, in the noninvasive vascular
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laboratory, in the peripheral vascular catheterization labo-
ratory, and on the vascular surgery service. They will need to
acquire knowledge of magnetic resonance imaging as it
relates to the diagnosis of vascular disease. Specific details
regarding this training curriculum will be published when
the entire COCATS-2 document is reviewed and approved
by the College’s Board of Trustees.
ORGANIZATIONS WORKING TOGETHER
FOR VASCULAR DISEASE GUIDELINES
Because the field of vascular medicine is multidisciplinary,
there are societies that have been working together on
several levels to identify the characteristics required for
establishing Vascular Centers of Excellence. Organiza-
tions involved in the vascular minisummit held in Chicago
in April 2000 included the ACC, the Society of Vascular
Surgery, the Society of Cardiovascular and Interventional
Radiology, and the Society of Vascular Medicine and
Biology. This event highlighted numerous models of care
that could be used to organize peripheral vascular disease
management for optimal patient outcomes.
In collaboration with the American Heart Association
(AHA), the College is planning a practice guideline on
peripheral vascular disease. Also in development by the
ACC, the AHA, and the American College of Physicians–
American Society of Internal Medicine is a clinical compe-
tence statement on peripheral vascular disease. The writing
group for this document is being chaired by a peripheral
vascular specialist, with co-chairs appointed by the AHA to
represent the fields of vascular radiology and vascular
surgery. Also included on the writing group are members of
the Society of Cardiovascular Interventional Radiology, the
Society of Vascular Surgery, and the American Association
of Vascular Surgery. Clearly, this undertaking will bring
together the expertise of many specialists from different
training backgrounds, all of whom have skills that are
relevant to the high-quality care required for management
of patients with peripheral vascular disease. The document
to be generated from this task force will deal with all aspects
of vascular medicine, including vascular interventional pro-
cedures.
ISSUES RELEVANT TO VASCULAR INTERVENTION
Several issues should be recognized regarding vascular
intervention in patients with peripheral vascular disease.
The operator who performs noncoronary vascular interven-
tional procedures should have sufficient cognitive knowl-
edge concerning the particular pathophysiologic state being
treated, in addition to technical expertise for performance of
the procedure. Certainly, this is highly relevant in renovas-
cular obstructive disease, in which the cognitive knowledge
base concerning the appropriateness of case selection is
quite complex and the ocular stenotic reflex for stenting any
obstructive lesion must be avoided. Of particular concern is
a growing trend for some operators to perform “total body
angiography” as an adjunct to diagnostic cardiac catheter-
ization. There is concern with the growing number of
insurance claims submitted for multiple angiograms at one
sitting. Some of these diagnostic studies are being per-
formed on 35-mm cine film using 9-inch intensifiers with-
out subtraction. The diagnostic quality of the studies is
often suboptimal. If adjunctive peripheral angiography is
not clinically indicated, then patients are subjected to an
excessive amount of contrast agent without benefit. Thus,
for cardiologists performing these procedures, they should
be performed not only in a high-quality manner but also for
the appropriate clinical indications, and they should be done
according to evidence-based practice guidelines.
Peripheral vascular disease is in many ways a unique area
for treatment because it presents such wide-ranging oppor-
tunities for physician collaboration. Although its scope
makes many different models of care possible, the only
models that should be on the table are those that put the
highest-quality patient care first. The cardiovascular special-
ist has a major role for providing comprehensive medical
care for the patient with atherosclerosis, whether such a
patient presents with vascular disease, coronary artery dis-
ease, or both.
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